A novel targeted alpha-particle therapy (TAT), 225Ac-MTI-201, targets the melanocortin 1 receptor (MC1R) which is highly expressed in metastatic uveal melanoma (MUM) and is currently in a first-in-human clinical trial. The favorable qualities of TAT include t...
Author profile
Eduardo G. Moros, PhD
Moffitt Cancer Center
Exploration of the Radiobiology of a Novel Targeted Alpha Therapy
Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine
Online Dose Verification & Anomaly Detection Using Radiation Acoustic Imaging In Proton and Electron Radiotherapy
Ensuring precise delivery of radiotherapy is paramount, especially in high dose rate settings where small deviations can create large, unplanned doses, jeopardizing patient safety and treatment outcome. Current dosimetry and QA methods operate on signals anal...
Poster Program · Therapy Physics
A Pre-Clinical Study of in vivo Irai and Biological Response during Flash and Conventional Electron Irradiation
Ionizing radiation acoustic imaging (iRAI) is a noninvasive technique for monitoring radiation delivery. Although iRAI acquisition during irradiation has been demonstrated, its use to quantify spatial dose variations alongside biological measurements under FL...
Proffered Program · Therapy Physics